Harness Expression Testing for Your Drug Discovery Research

Aug 08 2013

The ability to identify and measure biomarkers with high accuracy and sensitivity is vital in making critical go/no-go decisions in pharmacogenic investigations. Expression testing can provide early signs of efficacy and toxicity, confirming or refuting theories for mechanism and indication. We have recently expanded our expression testing offerings to now include OpenArray® technology on the QuantStudio™ 12K Flex Real-Time PCR System.
 
Charles River expression testing offers:

• Flexibility: Over 43,000 expression profiles or more than 110,000 genotypes can be performed

• Fast results: High-throughput system allows us to screen over 5,184 genotyping samples or more than 2,304 expression samples per work day

• Small sample volumes: Testing requires only nanoliter volumes, saving precious samples

• Custom and pre-validated panels: Either designed by our expert staff or obtained from Life Technologies™

In addition to expression testing, Charles River provides a wide set of genomics-based biomarker assays that can be integrated into your overall study design. Contact us at askcharlesriver@crl.com to leverage our expression testing and biomarker & analytical services in your drug or biological product development process.

Related Information

• Expression Testing

• Zygosity Testing

• Zygosity and Expression Testing Datasheet

• Biomarker & Analytical Services